NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 156 filers reported holding NEOGENOMICS INC in Q2 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,727,000 | +13.2% | 90,331 | +29.8% | 0.01% | +12.5% |
| Q2 2019 | $1,526,000 | +89.6% | 69,581 | +76.7% | 0.01% | +100.0% |
| Q1 2019 | $805,000 | +59.7% | 39,369 | -1.5% | 0.00% | +33.3% |
| Q4 2018 | $504,000 | -15.6% | 39,959 | +2.6% | 0.00% | 0.0% |
| Q3 2018 | $597,000 | +16.6% | 38,931 | -0.5% | 0.00% | 0.0% |
| Q2 2018 | $512,000 | +186.0% | 39,107 | +78.2% | 0.00% | +200.0% |
| Q1 2018 | $179,000 | -8.7% | 21,949 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $196,000 | -36.2% | 22,136 | -19.7% | 0.00% | -50.0% |
| Q3 2017 | $307,000 | +19.9% | 27,578 | -3.5% | 0.00% | 0.0% |
| Q2 2017 | $256,000 | +39.9% | 28,569 | +22.9% | 0.00% | +100.0% |
| Q1 2017 | $183,000 | -31.7% | 23,239 | -26.1% | 0.00% | -50.0% |
| Q4 2016 | $268,000 | +135.1% | 31,433 | +120.0% | 0.00% | +100.0% |
| Q2 2016 | $114,000 | – | 14,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |